Results 141 to 150 of about 2,938 (199)

Narrative review on ethical and psychological issues raised by genetic and genomic testing in pediatric oncology care. [PDF]

J Genet Couns
Droin-Mollard M, Hervouet L, Lahlou-Laforêt K, de Montgolfier S.   +3 more
europepmc   +1 more source

Sex-dependent interferon signaling contributes to female-biased vulnerability in Alzheimer's disease. [PDF]

J Neuroinflammation
López-López V, Iniesta G, Galán-Ganga M, Expósito-Coca A, Durán-Laforet V, Bhojwani-Cabrera AM, Navarrón CM, Guillot-Fernández M, Venero JL, Sánchez-Mut JV, Barco A, Giralt A, López-Atalaya JP.   +12 more
europepmc   +1 more source

Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale. [PDF]

Eur J Neurol
van Kooten HA, Horton MC, Wenninger S, Babačić H, Schoser B, Lefeuvre C, Taouagh N, Laforêt P, Segovia S, Díaz-Manera J, Claeys KG, Mongini T, Musumeci O, Toscano A, Hundsberger T, Brusse E, van Doorn PA, van der Ploeg AT, van der Beek NAME, European Pompe Consortium study group on outcome measures.   +19 more
europepmc   +1 more source

Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024. [PDF]

Eur J Neurol
Schoser B, van der Beek NAME, Broomfield A, Brusse E, Diaz-Manera J, Hahn A, Hundsberger T, Kornblum C, Kruijshaar M, Laforet P, Mengel E, Mongini T, Orlikowski D, Parenti G, Pijnappel WWMP, Roberts M, Scherer T, Toscano A, Vissing J, van den Hout JMP, van Doorn PA, Wenninger S, van der Ploeg AT.   +22 more
europepmc   +1 more source

<i>MYH7</i>-related myopathies: clinical, myopathological and genotypic spectrum in a multicentre French cohort. [PDF]

J Neurol Neurosurg Psychiatry
Bahout M, Severa G, Kamoun E, Bouhour F, Pegat A, Toutain A, Lagrange E, Duval F, Tard C, De la Cruz E, Féasson L, Jacquin-Piques A, Richard P, Métay C, Cavalli M, Romero NB, Evangelista T, Sole G, Carlier RY, Laforêt P, Acket B, Behin A, Fernández-Eulate G, Léonard-Louis S, Quijano-Roy S, Pereon Y, Salort-Campana E, Nadaj-Pakleza A, Masingue M, Malfatti E, Stojkovic T, Villar-Quiles RN.   +31 more
europepmc   +1 more source

When resources run short: the inhibitory effect of economic scarcity on third-party punishment. [PDF]

Front Psychol
Liang H, Li J.
europepmc   +1 more source

Lysosomal impairments in Pompe disease are associated with altered T cell homeostasis and intrinsic metabolic dysregulation

Costa-Verdera H, Gargaro M, Cagin U, Manni G, Scalisi G, Veron P, Barcelos ECS, Pieroni B, Mencarelli G, Ricciuti D, Nemazanyy I, Sanatine P, Wittenberghe Lv, Laforêt P, Gross D, Ronzitti G, Fallarino F, Mingozzi F.   +17 more
europepmc   +1 more source

Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registry. [PDF]

Eur J Neurol
Retailleau E, Lefeuvre C, De Antonio M, Bouhour F, Tard C, Salort-Campana E, Lagrange E, Béhin A, Solé G, Noury JB, Sacconi S, Magot A, Pakleza AN, Orlikowski D, Beltran S, Spinazzi M, Cintas P, Fournier M, Bouibede F, Prigent H, Nicolas G, Taouagh N, El Guizani T, Attarian S, Arrassi A, Hamroun D, Laforêt P.   +26 more
europepmc   +1 more source

Effect of mesenchymal stem cells on the host response in severe community-acquired pneumonia. [PDF]

Thorax
Reijnders TDY, Laterre PF, François B, Sánchez García M, van Engelen TSR, Sie D, Scicluna BP, Ostanin DV, Galinsky KJ, Butler JM, Lombardo E, van der Poll T, SEPCELL study group.   +12 more
europepmc   +1 more source